KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) FCF Margin (2016 - 2025)

Globus Medical's FCF Margin history spans 15 years, with the latest figure at 30.08% for Q4 2025.

  • For Q4 2025, FCF Margin rose 1491.0% year-over-year to 30.08%; the TTM value through Dec 2025 reached 25.18%, up 910.0%, while the annual FY2025 figure was 25.18%, 910.0% up from the prior year.
  • FCF Margin reached 30.08% in Q4 2025 per GMED's latest filing, down from 41.47% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 44.62% in Q4 2021 to a low of 1.04% in Q2 2022.
  • Average FCF Margin over 5 years is 20.08%, with a median of 17.26% recorded in 2022.
  • Peak YoY movement for FCF Margin: crashed -2425bps in 2022, then soared 2779bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 44.62% in 2021, then decreased by -8bps to 40.9% in 2022, then tumbled by -59bps to 16.79% in 2023, then dropped by -10bps to 15.17% in 2024, then soared by 98bps to 30.08% in 2025.
  • Per Business Quant, the three most recent readings for GMED's FCF Margin are 30.08% (Q4 2025), 41.47% (Q3 2025), and 0.7% (Q2 2025).